MoneyWorks4Me

Raymed Labs informs about integrated filing

14 Feb 2025 Evaluate

In accordance with amendments to the SEBI (Listing Obligations and Disclosure Requirements) (Third Amendment) Regulations, 2024 read with SEBI Circular No. SEBI/HO/CFD/CFD-PoD2/CIR/P/2024/185 dated 31st December, 2024, BSE Circular No. 20250102-4 and NSE Circular No. NSE/CML/2025/02 dated 2nd January, 2025, Raymed Labs has informed that it enclosed the Integrated Filing (Financial) for the third quarter and nine-months ended 31st December, 2024.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Uflex 663.05
EPL 238.55
AGI Greenpac 803.90
Huhtamaki India 242.40
TCPL Packaging 4107.35
View more..